Anxiety Treatment Research Study
Researchers at the University of Texas at Austin are conducting an evidence-based treatment study for a range of anxiety-related problems. This study aims to predict who is most likely to respond to cognitive behavior therapy (CBT). Help further research and enroll today!
Compensation Provided
18-70 Years Old
Anxiety- or Stress-Based Disorders
Fast Facts
English Proficiency Needed
North and South Central Austin
Study Background
Help our researchers learn to predict responsiveness to cognitive behavioral therapy.
Anxiety-, obsessive-compulsive, and trauma- and stressor-related disorders reflect a significant public health problem. These disorders are usually treated with cognitive behavioral therapy (CBT), but this doesn't work for all patients. We want to identify and test a biomarker that may help predict whether patients will respond to CBT.
This study is designed to evaluate the predictive power of a novel biomarker based on a CO2 breathing challenge. We will assess physical and emotional reactivity to two breathing exercises completed prior to a 12-week course of CBT. Then, we will determine how such reactivity relates to treatment outcomes in individuals with several forms of anxiety-related problems. The 12 sessions of exposure-based CBT are offered free of charge.
Your participation in this study may lead to better treatment approaches for with anxiety- and fear-related disorders. Help advance research and join our compensated study today!
Anxiety-, obsessive-compulsive, and trauma- and stressor-related disorders reflect a significant public health problem. These disorders are usually treated with cognitive behavioral therapy (CBT), but this doesn't work for all patients. We want to identify and test a biomarker that may help predict whether patients will respond to CBT.
This study is designed to evaluate the predictive power of a novel biomarker based on a CO2 breathing challenge. We will assess physical and emotional reactivity to two breathing exercises completed prior to a 12-week course of CBT. Then, we will determine how such reactivity relates to treatment outcomes in individuals with several forms of anxiety-related problems. The 12 sessions of exposure-based CBT are offered free of charge.
Your participation in this study may lead to better treatment approaches for with anxiety- and fear-related disorders. Help advance research and join our compensated study today!
Study Background Help our researchers learn to predict responsiveness to cognitive behavioral therapy. Anxiety-, obsessive-compulsive, and trauma- and stressor-related disorders reflect a significant public health problem. These disorders are usually treated with cognitive behavioral therapy (CBT), but this doesn't work for all patients. We want to identify and test a biomarker that may help predict whether patients will respond to CBT. This study is designed to evaluate the predictive power of a novel biomarker based on a CO2 breathing challenge. We will assess physical and emotional reactivity to two breathing exercises completed prior to a 12-week course of CBT. Then, we will determine how such reactivity relates to treatment outcomes in individuals with several forms of anxiety-related problems. The 12 sessions of exposure-based CBT are offered free of charge. Your participation in this study may lead to better treatment approaches for with anxiety- and fear-related disorders. Help advance research and join our compensated study today! |
Additional Information
This study is designed to evaluate the predictive power of a novel biomarker based on a CO2 challenge, thus addressing the central question "can this easy-to-administer assay aid clinicians in deciding whether or not to initiate exposure-based therapy?"
You may qualify for our study if you meet the following criteria.
Inclusion Criteria:
Inclusion Criteria:
- 18-70 years of age
- Panic disorder (with or without an agoraphobia diagnosis), social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder, or post-traumatic stress disorder
- Proficient in English
- Lifetime history of bipolar or psychotic disorders, substance use disorders, (other than nicotine) or eating disorder in the past 6 months
- Serious cognitive impairment
- Active suicidal ideation or suicidal behavior in the past 6 months
- Medical conditions that disallow the breathing challenge (cardiac arrhythmia, cardiac failure, asthma, lung fibrosis, high blood pressure, epilepsy, or stroke)
- Pregnant or breastfeeding
- Ongoing psychotherapy for the primary disorder
- New medication started in the past 8 weeks
If eligible, participation involves:
(a) 2 in-person pre-treatment assessment visits;
(b) 12-weekly in-person therapy sessions with a license-eligible level therapist;
(c) 12 brief weekly online assessments to track your progress; and
(d) 2 online follow-up assessments occurring 1-week and 3-months after treatment.
(a) 2 in-person pre-treatment assessment visits;
(b) 12-weekly in-person therapy sessions with a license-eligible level therapist;
(c) 12 brief weekly online assessments to track your progress; and
(d) 2 online follow-up assessments occurring 1-week and 3-months after treatment.
Eligible participants will be compensated up to $300.
There is no cost to participate in our research study.